Loading...

Shield Therapeutics plc

SHIEF•PNK
Healthcare
Drug Manufacturers - Specialty & Generic
$0.13
$0.00(0.00%)
U.S. Market opens in 14h 20m

Shield Therapeutics plc (SHIEF) Stock Overview

Explore Shield Therapeutics plc’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap134.6M
P/E Ratio-8.87
EPS (TTM)$-0.02
ROE1.01%
Fundamental Analysis

AI Price Forecasts

1 Month$0.15
3 Months$0.16
1 Year Target$0.19

SHIEF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Shield Therapeutics plc (SHIEF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 44.10, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.19.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -8.87 and a market capitalization of 134.6M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
-10.83%
3-Month Change
-14.50%
6-Month Change
29.23%
Year-to-Date (YTD) Change
-13.70%
1-Year Change
270.59%
3-Year Change
64.71%
5-Year Change
-77.89%
All-Time (Max) Change
-94.85%

Contact Information

https://www.shieldtherapeutics.com
44 1915 118 500
Northern Design Centre, Gateshead, NaN, NE8 3DF

Company Facts

63 Employees
IPO DateDec 6, 2019
CountryGB
Actively Trading

Frequently Asked Questions